Agilent Technologies (NYSE:A) Announces Earnings Results

Key Points

• Agilent Technologies beat expectations in its latest quarter, reporting EPS of $1.49 versus the $1.40 consensus and revenue of $1.84 billion versus $1.80 billion expected.
• The company raised guidance for FY 2026 to EPS of $6.00-$6.10 and for Q3 2026 to EPS of $1.48-$1.50, signaling management confidence in continued performance.
• Analyst sentiment remains positive, with RBC initiating coverage at Outperform and a $153 target, while Robert W. Baird lifted its target to $156 and reiterated an Outperform rating.

Agilent Technologies (NYSE:A - Get Free Report) released its earnings results on Wednesday. The medical research company reported $1.49 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.40 by $0.09, FiscalAI reports. Agilent Technologies had a return on equity of 24.49% and a net margin of 18.26%.The firm had revenue of $1.84 billion for the quarter, compared to analysts' expectations of $1.80 billion. Agilent Technologies updated its FY 2026 guidance to 6.000-6.100 EPS and its Q3 2026 guidance to 1.480-1.500 EPS.

Agilent Technologies Trading Up 0.6%

Shares of Agilent Technologies stock traded up $0.74 during midday trading on Wednesday, reaching $115.82. The company had a trading volume of 2,899,904 shares, compared to its average volume of 2,183,498. The stock has a fifty day moving average price of $114.91 and a 200 day moving average price of $129.01. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.07 and a quick ratio of 1.59. The firm has a market cap of $32.73 billion, a PE ratio of 25.57, a P/E/G ratio of 2.42 and a beta of 1.22. Agilent Technologies has a fifty-two week low of $108.35 and a fifty-two week high of $160.27.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 22nd. Investors of record on Tuesday, June 30th will be paid a $0.255 dividend. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend is Tuesday, June 30th. Agilent Technologies's payout ratio is currently 22.52%.

Hedge Funds Weigh In On Agilent Technologies

Institutional investors have recently added to or reduced their stakes in the business. State of Wyoming acquired a new position in Agilent Technologies in the second quarter valued at approximately $35,000. Transamerica Financial Advisors LLC raised its position in Agilent Technologies by 180.8% in the 4th quarter. Transamerica Financial Advisors LLC now owns 337 shares of the medical research company's stock valued at $46,000 after buying an additional 217 shares during the last quarter. Johnson Financial Group Inc. purchased a new stake in Agilent Technologies in the 3rd quarter valued at $49,000. DV Equities LLC purchased a new stake in Agilent Technologies in the 4th quarter valued at $54,000. Finally, Itau Unibanco Holding S.A. bought a new position in Agilent Technologies in the 4th quarter valued at $58,000. 87.41% of the stock is owned by institutional investors and hedge funds.

Agilent Technologies News Summary

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent raised its FY 2026 outlook, guiding for EPS of $6.00-$6.10 and revenue of $7.4 billion-$7.5 billion, both in line to slightly above Wall Street expectations. The company also guided Q3 EPS to $1.48-$1.50 on revenue of $1.8 billion-$1.9 billion, signaling stable demand and execution.
• Positive Sentiment: Royal Bank of Canada initiated/started coverage with an Outperform rating and a $153 price target, implying meaningful upside from current levels. Benzinga
• Positive Sentiment: Robert W. Baird also raised its price target to $156 and reiterated an Outperform rating, reinforcing analyst confidence ahead of the next earnings cycle. Benzinga
• Neutral Sentiment: Recent product and conference announcements, including new GC systems, a MAM solution for biopharma quality control, and cancer research showcases, highlight ongoing innovation but are less likely to move the stock immediately.

Analyst Ratings Changes

A number of research firms have issued reports on A. Morgan Stanley decreased their target price on Agilent Technologies from $180.00 to $160.00 and set an "overweight" rating on the stock in a research report on Tuesday, March 3rd. Barclays decreased their target price on Agilent Technologies from $150.00 to $140.00 and set an "overweight" rating on the stock in a research report on Tuesday, April 14th. Royal Bank Of Canada began coverage on Agilent Technologies in a research report on Wednesday. They issued an "outperform" rating and a $153.00 target price on the stock. UBS Group decreased their target price on Agilent Technologies from $180.00 to $165.00 and set a "buy" rating on the stock in a research report on Thursday, February 26th. Finally, TD Cowen reduced their price target on Agilent Technologies from $170.00 to $157.00 and set a "buy" rating on the stock in a report on Thursday, February 26th. Two investment analysts have rated the stock with a Strong Buy rating, twelve have given a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Buy" and an average target price of $162.40.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.